Alkermes (ALKS) Assets Average (2011 - 2026)
Alkermes (ALKS) posted quarterly Assets Average of $4.3 billion for Q2 2026, up 99.58% year-over-year from $2.2 billion in Q2 2025, and up 28.26% quarter-over-quarter from $3.4 billion in Q1 2026.
Alkermes (ALKS) Assets Average (2011 - 2026) Analysis & Trends
Alkermes (ALKS) has reported Assets Average for 16 consecutive years, with $4.3 billion the latest figure, recorded in Q2 2026.
- In Q2 2026, Assets Average rose 99.58% year-over-year to $4.3 billion; the TTM figure through Jun 2026 stood at $4.3 billion (up 99.58% YoY), while the FY2025 annual figure was $2.3 billion, up 8.37% from the prior year.
- Assets Average improved to $4.3 billion in Q2 2026 per ALKS's latest filing, from $3.4 billion in the prior quarter.
- Across five years, Assets Average topped out at $4.3 billion in Q2 2026 and bottomed at $1.9 billion in Q1 2023.
- Historically, Assets Average has averaged $2.3 billion across 5 years, with a median of $2.1 billion in 2024.
- Annual changes were most pronounced in 2024 — Assets Average slipped 4.63% — and 2026, when it soared 99.58%.
- Alkermes' Assets Average stood at $2.0 billion in 2022, then climbed by 13.05% to $2.2 billion in 2023, then retreated by 4.63% to $2.1 billion in 2024, then gained by 14.38% to $2.4 billion in 2025, then soared by 79.62% to $4.3 billion in 2026.
- Business Quant data shows ALKS's Assets Average at $4.3 billion in Q2 2026, $3.4 billion in Q1 2026, and $2.4 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 39.95 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 15.12 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 98.59 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 6.97 Bn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 35.94 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 5.13 Bn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 13.39 Bn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | 5.97 Bn |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn | 4.33 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.33 Bn |
| Mar 31, 2026 | 3.37 Bn |
| Dec 31, 2025 | 2.41 Bn |
| Sep 30, 2025 | 2.29 Bn |
| Jun 30, 2025 | 2.17 Bn |
| Mar 31, 2025 | 2.07 Bn |
| Dec 31, 2024 | 2.11 Bn |
| Sep 30, 2024 | 2.18 Bn |
| Jun 30, 2024 | 2.17 Bn |
| Mar 31, 2024 | 2.13 Bn |
| Dec 31, 2023 | 2.21 Bn |
| Sep 30, 2023 | 2.23 Bn |
| Jun 30, 2023 | 2.05 Bn |
| Mar 31, 2023 | 1.94 Bn |
| Dec 31, 2022 | 1.95 Bn |
| Sep 30, 2022 | 1.95 Bn |
| Jun 30, 2022 | 1.97 Bn |
| Mar 31, 2022 | 2.00 Bn |
| Dec 31, 2021 | 2.01 Bn |
| Sep 30, 2021 | 1.97 Bn |